|
PRMT5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.81879999739243E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.69210000245235E-08 |
| Normal-vs-Stage2 |
9.796200E-03 |
| Normal-vs-Stage3 |
1.683800E-01 |
| Normal-vs-Stage4 |
3.208600E-01 |
| Stage1-vs-Stage2 |
9.800400E-01 |
| Stage1-vs-Stage3 |
1.352210E-01 |
| Stage1-vs-Stage4 |
4.357800E-01 |
| Stage2-vs-Stage3 |
3.066600E-01 |
| Stage2-vs-Stage4 |
5.235800E-01 |
| Stage3-vs-Stage4 |
8.727600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.29729999998052E-06 |
| Normal-vs-AfricanAmerican |
3.33140000030596E-07 |
| Normal-vs-Asian |
3.148600E-01 |
| Caucasian-vs-AfricanAmerican |
2.152600E-01 |
| Caucasian-vs-Asian |
8.820800E-01 |
| AfricanAmerican-vs-Asian |
8.005800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75809999891641E-09 |
| Normal-vs-Female |
5.171600E-02 |
| Male-vs-Female |
3.418300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.076480E-03 |
| Normal-vs-Extreme_Weight |
3.56120000044591E-07 |
| Normal-vs-Obese |
4.240600E-03 |
| Normal-vs-Extreme_Obese |
3.245700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.234800E-01 |
| Normal_Weight-vs-Obese |
4.273600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.278000E-01 |
| Extreme_Weight-vs-Obese |
1.318780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.744000E-01 |
| Obese-vs-Extreme_Obese |
2.565400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.254400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.7219999999989E-05 |
| Normal-vs-Age(61-80Yrs) |
3.20799999897758E-08 |
| Normal-vs-Age(81-100Yrs) |
7.724400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.037800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.625800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.773570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.365800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.173600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.189200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.52369996806601E-09 |
| Normal-VS-Type2 PRCC |
4.618000E-03 |
| Normal-VS-KIRP CIMP |
4.630800E-01 |
| Normal-VS-Unclassified PRCC |
6.797200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.470960E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.672000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.374400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.405400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.009400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.391600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.1255000000956E-07 |
| Normal-vs-N1 |
7.569400E-01 |
| Normal-vs-N2 |
2.70250000045102E-07 |
| N0-vs-N1 |
3.324100E-02 |
| N0-vs-N2 |
1.209800E-01 |
| N1-vs-N2 |
5.540300E-02 |
|
|
